The file's text, extracted by GovTribe without its formatting.
RFP-25-81029
Attachment H3
Technical Specifications
Quality Assurance/Quality Control Criteria
A. Data Quality Assessment Data Quality Assessment provides guidance as to the quality of data necessary to meet a desired purpose. Sampling events and specific projects must define the goals of data collection and interpretation. Table 1, below, specifies OWQ data quality assessments (DQA) for sampling, chain-of-custody, Vendor analyses, and reporting. OWQ’s samples for the purposes of this contract are treated at Data Quality Assessment 4 (DQA4), unless otherwise specified in a Task or authorized by the responsible gatekeeper (IDEM/OWQ contact person) prior to analysis by the Contractor.
Table 1.: Data Quality Assessments
| DQA LEVEL |
| DATA TYPE |
| DESCRIPTION |
| 1 |
| Screening Data |
| The results are usually generated onsite and have no QC checks. Analytical results, which have no QC checks or no precision or accuracy information or no detection limit calculations, but just numbers, are included in this category. Primarily, onsite data are used for presurveys and for preliminary rapid assessment. |
| 2 |
| Field Analysis Data |
| Data is recorded in the field or laboratory on calibrated or standardized equipment. Field duplicates are measured on a regular periodic basis. Calculations may be done in the field or later at the office. Analytical results, which have limited QC checks, are included in this category. Detection limits and ranges have been set for each analysis. The QC checks information for field or laboratory results is useable for estimating precision, accuracy, and completeness for the project. Data from this category are used independently for rapid assessment and preliminary decisions. |
| 3 |
| Laboratory Analytical Data |
| Analytical results include QC check samples for each batch of samples from which precision, accuracy, and completeness can be determined. Method detection limits (MDLs) have been determined using 40 CFR Part 136 Appendix B. Additionally, all reporting information required in the laboratory contract, and in the IDEM Surface Water Quality Monitoring and TMDL QAPP, especially Table A9-1, are included in the analytical data reports. Raw data, chromatograms, spectrograms, and bench sheets are not included as part of the analytical report, but are maintained by the contract laboratory for easy retrieval and review. Data can be elevated from DQA Level 3 to DQA Level 4 by the inclusion of this information in the data report and the QC data are reported using CLP forms or CLP format. Data falling under this category are considered as complete, legally defensible, and used for regulatory decisions. |
Data Analytical results mostly meet the USEPA required Contract Laboratory Program (CLP) data analysis, Contract Required Quantification Limits (CRQL), and validation procedures. QC data are reported on CLP forms or CLP format. Raw data, chromatograms, spectrograms, and bench sheets are included as part of the analytical report. Additionally, all reporting information required in the laboratory contract, and in the IDEM Surface Water Quality Monitoring and TMDL QAPP, especially Table A9-1, are included in the analytical data reports. Data falling under this category are considered as complete, legally quantitative in value, and used for regulatory decisions.
B. Quality Assurance/Quality Control and Documentation 1.
Overview Quality control, in sampling and analysis, is a systematic approach to identifying, measuring, and minimizing errors introduced during sample acquisition and laboratory analysis. Quality control is a component of the overall process of quality assurance. Laboratories must not only look at completion of a method as satisfying the general requirements for quality control, but must also evaluate their overall processes and the quality of their performance over time. Only by maintaining an evaluation of an analytical methodology over time, can a single sample result be validated.
2.
Quality Assurance/Quality Control Plan Contractors must have and maintain a documented Quality Assurance/Quality Control (QA/QC) Program, capable of demonstrating that data has a specified degree of precision and reliability. An acceptable QA/QC program would be one patterned after a publication such as the “Handbook for Analytical Quality Control in Water and Wastewater Laboratories”, USEPA 600/4-79/019. Contractors must be able to validate each method used and each analysis performed by that method using the QA/QC Program.
QA/QC measures must be documented. All documentation must be maintained and made available for the use of IDEM/OWQ for five (5) years after the expiration date of this Contract. QA/QC documentation must be submitted as required I the following sections.
Contractors must maintain and document continual evaluation of the accuracy and precision of an analytical procedure and the ability of individual analysts to meet laboratory performance for a procedure.
QA/QC Criteria a.
Required Preservation and Holding Times
Analysis of a sample must begin within holding time. The beginning of an analysis or the end of the sample holding time is considered to be the time at which the Laboratory Reagent Blank is analyzed.
b. Analytical QA/QC Criteria
Contractors must follow the QA/QC criteria specified in the analytical method being performed. In the event that a method does not specify QA/QC criteria the following minimum criteria must be applied:
1. Initial calibration or linear calibration at least once per year.
2. Method detection limit determined in accordance with 40CFR, Part 136, Appendix B, at least once per year.
3. Continuing calibration check per sample batch. Typically a continuing calibration check should be run even with analytical procedures requiring a linear calibration.
4. Calibration blank per sample batch.
5. Laboratory fortified blank per sample batch.
6. Quality control standard on a quarterly basis.
c. Procedural calibration standards
Several methods use procedural calibration standards that do not require a separate LFB and CCC. If methods requiring an LFB and CCC do not state that the LFB and CCC are equivalent, a separate LFB and CCC must be analyzed, unless approved by the responsible IDEM/OWQ contact.
c.
Discrepancies
When a method and Table 2 of this Attachment are in direct conflict over QA/QC procedures or Table 2 of this Attachment lists QA/QC procedures not found in the method, Table 2 of this Attachment takes precedence. Offerors may utilize this judgment without penalty for a first occurrence of a direct conflict: however, Offerors must notify the responsible IDEM/OWQ gatekeeper after the first occurrence of a direct conflict. Failure to notify IDEM/OWQ after the first occurrence of a direct conflict may result in denial of future payments. No notification is required for QA/QC retroactively applied to pre-1991 methods as listed in Table 2 of this Attachment.
4.
Analytical Control a.
General Criteria
This section does not constitute all conditions under which an analysis would be deemed out‑of‑control or for remedies that a Contractor must employ to bring an analysis into control. The respective method and Table 2 of this Attachment must be consulted for these criteria: however, the conditions listed below supersede any method criteria, when in conflict with the method. Contractors are responsible for maintaining analytical controls necessary to meet the method QC specifications listed in Table 2 of this Attachment, and/or good judgment.
Good judgment is keeping consistent with the quality control necessary to justify a single sample result. For example, this is reflected in the retroactive application of method independent QA/QC criteria by IDEM/OWQ. There is no excuse for failure to monitor and address analytical control conditions by a Contractor.
IDEM/OWQ will be the sole judge of compliance with analytical control. Contractors found to not be employing and meeting the specifications outlined in the respective method, Table 2 of this Attachment, or employing good judgment, will be notified of the specific conditions and given the opportunity to correct any deficiency(s). Failure to correct the specified deficiency(s) may result in denial of payment for affected analyses and may result in termination of the Contractor’s contract in part or whole.
b.
Out-of-Control
1) Control Criteria
Analyses must be conducted in-control, as specified in the method and this Section. If an analysis or instrument is found to be out-of-control, the analyst must perform the corrective action measures necessary to bring the system back into control. All analytical and QA/QC samples analyzed since the last acceptable QC criteria must be reanalyzed after the analysis is brought into control. Contractors must document and report out-of-control operations, QC parameters, remedies, and reanalyses in the analytical report Narrative.
2) Holding Times
When samples are analyzed out of holding time, the analysis is deemed out-of-control, unless the analysis is approved by the IDEM/OWQ contact person.
3) Laboratory Reagent Blank (LRB) and Calibration Blanks The LRB or method blank and initial or continuing calibrations must be in control, prior to conducting an analytical run; otherwise the analysis is deemed out‑of‑control.
4) Internal Standards (IS) and Surrogate Standard (SS)
If a single IS or SS does not meet recovery criteria for a method during a batch run, the analysis will be considered in control: however, the analyst must take remedial measures to identify and correct the problem prior to future batches.
If the IS or SS retention window is not met per the analytical method, the analysis is deemed out‑of‑control. The IS retention time must be brought back into control and all samples reanalyzed since the last IS which met retention time criteria.
If two IS or SS, in a sample, do not meet recovery criteria, the analysis is deemed out‑of‑control.
If one or more IS or SS in consecutive samples do not meet recovery criteria, the analysis is deemed out‑of‑control.
If an analysis is out‑of‑control due to the failure of an IS or SS, a QC check sample must be analyzed following the last out‑of‑control sample. If the QC check sample meet recovery criteria, then the analysis is in control and the recovery failure may be due to matrix interferences. The Contractor should contact the responsible IDEM/OWQ contact person to see if reanalysis of the out‑of‑control sample(s) is required.
5) Matrix Spike/Matrix Spike Duplicate (MS/MSD)
Whenever the analytical procedure is “out of control,” the problem must be found, corrected, and the analysis repeated. The flagging of data as being “out-of-control without repeat analysis, is not acceptable. Analytical results reported when the procedure is operating “out-of-control” will be refused and payment will be withheld unless approved in writing by IDEM. Written approval may be given only in those situations where the results are needed and the sample cannot be analyzed again due to insufficient amount of sample remaining or a proper justification can be made using precision and accuracy data obtained by the method. Written approval will be entirely at the discretion of IDEM.
6) Laboratory Fortified Matrix (LFM)
If the analyses of an LFM does not agree with the true value within: +/- 20% for inorganic, volatile, and metals analyses; and +/-30% for pesticide, semivolatile and PCB analyses, and the LRB and CCC are in control, then the percent recovery failure is due to matrix interferences. Document the LFM matrix interference in the Narrative.
7) High Biased Samples
If a QC sample indicates a biased high result and the sample results are below detection limits for the all target compounds, reanalysis is not required.
Table 2: METHOD QUALITY CONTROL CRITERIA
| Test |
| VERSION : DATE |
| IC |
| MDLs |
| LCR or LDR |
| CALIBRATION BLANK |
| LRB, MB or PB |
| LCS or LFB |
| MS/MSD |
(LFM)
| CCC |
| IPC or LPC |
| QCS |
| Additional QC Requirements and Comments |
| methods not listed |
| NA |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 120.1 |
| :1982 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 130.1 |
| :1971 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 150.1 |
| :1982 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| QTRLY |
| Laboratories should be analyzing replicates on a at a rate of 1 per batch or 10%, whichever is greater.. Replicates should maintain an agreement of +/‑ 10% between replicates |
| QTRLY |
| Laboratories should be analyzing replicates on a at a rate of 1 per batch or 10%, whichever is greater.. Replicates should maintain an agreement of +/‑ 10% between replicates |
| QTRLY |
| Laboratories should be analyzing replicates on a at a rate of 1 per batch or 10%, whichever is greater.. Replicates should maintain an agreement of +/‑ 10% between replicates |
| QTRLY |
| Laboratories should be analyzing replicates on a at a rate of 1 per batch or 10%, whichever is greater.. Replicates should maintain an agreement of +/‑ 10% between replicates |
QTRLY
Laboratories should be analyzing replicates on a at a rate of 1 per batch or 10%, whichever is greater.. Replicates should maintain an agreement of +/‑ 10% between replicates
| 180.1 |
| 2.0:1993 |
| R |
| R, Y |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
R, AC
Verify 0.02 NTU resolution at three points from 0<X<1NTU, using freshly prepared Formazin on a quarterly basis. Maintain control charts on performance.
0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion.
| 200.7 |
| 4.4:1994 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. Serial Dilution required at 10X MDL. |
| 200.8 |
| 5.3:1994 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. |
| 200.9 |
| 2.2:1994 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. Serial Dilution required at 10X MDL. |
| 218.5 |
| :1982 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 218.6 |
| 3.3:1994 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R,Batch |
| R, Batch, QReps |
| R, 10% |
| R, Daily, 20 |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 245.1 |
| 3.0:1994 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 245.2 |
| 1974 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 245.5 |
| 2.3:1991 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 300.0 |
| 2.1:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R,Batch |
| R, Batch, QReps |
| R, 10% |
| R, Daily, 20 |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 310.1 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 3111B |
| 22nd ed.:2012 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. Serial Dilution required at 10X MDL. |
| 3112B |
| 22nd ed.:2012 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. Serial Dilution required at 10X MDL. |
| 3113B |
| 22nd ed.:2012 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. Serial Dilution required at 10X MDL. |
| 3114 |
| 22nd ed.:2012 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. Serial Dilution required at 10X MDL. |
| 325.2 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 330.1 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 330.5 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 335.4 |
| 1.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 350.1 |
| 2.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 350.3 |
| :1974 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 351.2 |
| 2.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 352.1 |
| :1971 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 353.2 |
| 2.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 354.1 |
| :1971 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 365.1 |
| 2.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 365.2 |
| :1971 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 370.1 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 375.2 |
| 2.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 376.1 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
QTRLY
Seed Blank & Glucose‑Glutamic Acid check required per batch. Labs must maintain control charts of blank and check solution performance. Control limits must be established in accordance with 5210B, p 6a.
| 410.1 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 8 & 9 of the method |
| 410.4 |
| 2.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 413.2 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| Labs must utilize reference oil (section 6.4) to develop initial percent recoveries based on a minimum of 10 replicates performed on separate days. Labs must update percent recoveries every 20 to 30 check samples. |
| 415.1 |
| :1974 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 418.1 |
| :1978 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 420.4 |
| 1.0:1993 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| R, Before Analysis, Batch, 12hr |
| R, Batch, 20S, 12hr |
| See Sect 9.10 |
| R, 12hr |
| R, DAILY |
| QTRLY |
| R, Before Analysis, Batch, 12hr |
| R, Batch, 20S, 12hr |
| R, Batch, 20S, 12hr |
| R, 12hr |
| QTRLY |
| Surrogate(s): DFTPP, endrin, 4,4'‑DDT |
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 10% of samples |
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 10% of samples |
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 10% of samples |
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 10% of samples |
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 10% of samples |
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 5% of samples |
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 5% of samples |
Internal Standard(s) and Surrogate(s): R, See Table 8
| R, After LFB, 12hr, 10S |
| R, Batch |
R, 12hr
QTRLY
| R, in Triplicate Monthly |
| R, 12hr, 10S |
R, 12hr, 10S
QTRLY
| R, After LFB, 12hr, 10S |
| R, 12hr, 10S |
R, 12hr, 10S
QTRLY
| After CCC |
| R, After LFB, 12hr, 10S |
| R, 12hr, 10S |
R, 12hr, 10S
QTRLY
| After CCC |
| R, After LFB, 12hr, 10S |
| R, 12hr, 10S |
R, 12hr, 10S
QTRLY
| After CCC |
| R, After LFB, 12hr, 10S |
| R, 12hr, 10S |
R, 12hr, 10S
QTRLY
| After CCC |
| R, After LFB, 12hr, 10S |
| R, 12hr, 10S |
R, 12hr, 10S
QTRLY
| After CCC |
| R, After LFB, 12hr, 10S |
| R, 12hr, 10S |
R, 12hr, 10S
QTRLY
R, After LFB, 12hr, 20S
| All samples w/labeled cmpds. |
| R, 12hr, 10S |
QTRLY
| 2130 |
| 22nd ed.:2012 |
| R |
| R, Y |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
R, AC
Verify 0.02 NTU resolution at three points from 0<X<1NTU, using freshly prepared Formazin on a quarterly basis. Maintain control charts on performance.
| 2320B |
| 22nd ed.:2012 |
| R |
| R, Y |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 2540B, C, D, E, F |
| 22nd ed.:2012 |
| R |
Contractors should run sample replicates on a 10% basis. Replicates should agree within +/-10%.
| 4500CL(‑)‑D, E |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500NH3-D, F |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500N(Org)-B, C |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500CN‑C, E, F, G, I |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500F(‑)‑B, C, D, E |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500NO2‑B |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500NO3‑D, E, F |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500P‑E, F |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 4500Si-D |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
R, Batch
Seed Blank & Glucose‑Glutamic Acid check required per batch. Labs must maintain control charts of blank and check solution performance. Control limits must be established in accordance with 5210B, p 6a.
| 5220B |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 5310 |
| 22nd ed.:2012 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| 6010C |
| 3.0:2000 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. |
| 6020A |
| 6.0:2004 |
| R |
| R, Y |
| R, Y |
| R, AC, 10S, End Batch |
| R, Batch, 20S |
| R, Batch |
| R, Batch, 10% |
| R, AC, 10S, End Batch |
| QTRLY |
| 0.02 NTU verification (180.1) must be conducted every 12hr when analyzing turbidity for omission of sample digestion. |
R, Batch
R, Batch, 10%
Run one (1) duplicate per 10 samples. RPD must be <= 30 %
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 5% of samples |
Internal Standard(s) and Surrogate(s): R, See Table 8
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 5% of samples |
Internal Standard(s) and Surrogate(s): R, See Table 8
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 5% of samples |
Internal Standard(s) and Surrogate(s): R, See Table 8
R, Before Analysis, Batch
| QTRLY |
| Laboratory Control Standard required 5% of samples |
Internal Standard(s) and Surrogate(s): R, See Table 8
| 9010B |
| 2.0:1996 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
| 9036 |
| 0:1986 |
| R |
| R, 6M |
| R, 6M |
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, 10% |
| R, AC |
| R, CB, 10S, End Batch |
| QTRLY |
| See sections 9 & 10 of the method |
6M R
6M
| R, AC, 10S, End Batch |
| R, Batch |
| R, Batch |
| R, Batch |
| R, Batch, 10% |
| R, CB, 10S, End Batch |
| 9221A, B, C, E |
| 22nd ed.:2012 |
R, AC, 10S, End Batch
R, Batch
| QTRLY |
| Duplicate analyses must be conducted on 10% of all samples and all positive routine samples. QC criteria found in 9020B must be |
followed. The most recent QC results determined in 9020B must be reported with each IDEM/OWQ sample set.
| 9222A, B, C, D |
| 22nd ed.:2012 |
R, AC, 10S, End Batch
R, Batch
| QTRLY |
| Duplicate analyses must be conducted on 10% of all samples and all positive routine samples. QC criteria found in 9020B must be |
followed. The most recent QC results determined in 9020B must be reported with each IDEM/OWQ sample set.
R, Batch, 10%
Run one (1) duplicate per 10 samples. RPD must be <= 30 %
R, Batch, 10%
Run one (1) duplicate per 10 samples. RPD must be <= 30 %
RFP-25-81029
Technical Specifications H3